POSSIBLE MECHANISMS OF TASTE IMPAIRMENT AS A CRUCIAL SYMPTOM OF COVID-19
Abstract
ABSTRAK
Latar Belakang: Pandemi Coronavirus Disease –19 (COVID-19) adalah sindrom pernafasan akut yang parah, disebabkan oleh Severe Acute Respiratory Syndrome Corona Virus–2 (SARS-CoV-2) dan berdampak di seluruh negara. Penyakit ini menyebar terutama melalui jalur pernapasan. Gangguan rasa pengecapan adalah salah satu gejala awal COVID-19. SARS-CoV-2 menyerang tubuh manusia melalui reseptor Angiotensin – Converting Enzyme 2 (ACE2). Populasi sel dengan peningkatan kadar ACE2 yang diekspresikan pada sel epitel paru, jantung, usus, ginjal, pembuluh darah, otak, dan mukosa mulut akan menjadi paling rentan terkena infeksi virus. Adhesi protein spike SARS-CoV-2 ke ACE2 menyebabkan penurunan regulasi ACE2, yang mengakibatkan peningkatan Angiontensin II (Ang II). Ang II memiliki efek menurunkan respon terhadap rasa pengecapan dan mengatur amiloride – garam sensitif dan reaksi terhadap rasa manis. Tujuan: Menyoroti, mengeksplorasi dan menjelaskan kemungkinan mekanisme penurunan rasa pengecapan pada infeksi SARS-CoV-2. Metode: Menganalisis jurnal dari database Google Scholar, Perpustakaan Nasional Republik Indonesia, Science Direct, EBSCO, dan PubMed dari tahun 2011 sampai dengan tahun 2021. Kesimpulan: Patogenisitas dan kemampuan SARS-CoV-2 dalam gangguan rasa pengecapan melalui ACE2 yang mengarah akumulasi Angiotensin II dan mengakibatkan terjadinya penekanan respons rasa, namun masih dibutuhkan investigasi lebih lanjut untuk memastikan mekanisme yang pasti.
Kata kunci: COVID-19, SARS-CoV-2, gangguan pengecapan, ACE2, Ang II, amiloride
ABSTRACT
Background: Corona virus disease – 19 (COVID-19) pandemic is a syndrome caused by infection of severe acute respiratory syndrome corona virus–2 (SARS-CoV-2) and impacting all over the countries. Gustatory impairment is one of early illness and signs in COVID-19. The SARS-CoV-2 invades the person body via angiotensin – converting enzyme 2 (ACE2) receptors. Cell populations with elevated level of expressed ACE2 (epithelial cells of the pulmonary, cardiac, intestinal, renal, blood vessels, brain and oral mucosa) will be most vulnerable from viral infection. The adhesion of SARS- CoV-2 spike protein to ACE2 caused ACE2 downregulation, result in an enhancement of Angiontensin II (Ang II). Ang II has suppressive effects on gustatory responses and regulates amiloride – sensitive salt and sweet sense reactions. Purpose: Highlights and explores the possible mechanisms of the taste impairment of SARS-CoV-2 infection. Method: Journal analysis from Google Scholar, National Library of the Republic of Indonesia, Science Direct, EBSCO, and PubMed databases from 2011 to 2021. Conclusion The pathogenicity and capability of SARS-CoV-2 in taste impairment via ACE2 leading to Angiotensin II accumulation and as a consequence of suppressive effects on taste responses. Further investigation to ascertain its mechanism is needed.
Keywords: COVID-19, SARS-CoV-2, taste impairment, ACE2, Ang II, amiloride
Full Text:
PDFReferences
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan, et al. Coronavirus Disease 2019: Review of Current Literatures. Jurnal Penyakit Dalam Indonesia. Maret 2020; 7(1): 45-63
Noordien N, Mulder-van Staden S, Mulder R. In Vivo Study of Aerosol, Droplets and Splatter Reduction in Dentistry. Viruses. 2021 Sep 25;13(10):1928.
Zhou W, Zhong N, Zhu S, Chen Q, Li J. Coronavirus Prevention Handbook 101 Science – Based Tips That Could Save Your Life. Hubei Science and Technology Press,2020:1-28.
European Centre for Disease Prevention and Control. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update – 12 March 2020. Stockholm: ECDC; 2020.
Jin H, Hong C, Chen S, et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke & Vascular Neurology 2020;0.
Jiang X, Rayner S, Luo M‐H. Does SARS‐CoV‐2 have a longer incubation period than SARS and MERS? J Med Virol. 2020; 92:476–478.
Khalili M, Karamouzian M, Nasiri N, Javadi S, Mirzazadeh A, Sharifi H. Epidemiological Characteristics of COVID-19; a Systemic Review and Meta-Analysis [cited 2020 April 14]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.01.20050138v1.full.pdf
Lacobucci G. Sixty Seconds on Anosmia. BMJ. 2020;368:m1202
Coronavirus Disease 2019: Resources. [updated 2020; cited 2020 April 14]. Available from https://www.entnet.org/content/coronavirus-disease-2019-resources
Doremalen NV, Gamble A, Tamin A; Williamson B. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med; March 2020:1-4
11.Singer‑Cornelius T, Cornelius J, Oberle M, Metternich FU, Brockmeier SJ. Objective gustatory and olfactory dysfunction in COVID‑19 patients:
a prospective cross‑sectional study. European Archives of Oto-Rhino-Laryngology (2021) 278:3325–3332
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813.
Rodriguez-Morales AJ, Rodriguez-Morales AG, Méndez CA, Hernández-Botero S. Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and its Potential Relationship with the SARS-CoV-2 Divergence. Curr Trop Med Rep.2020; 7(3): 75–78
Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka. N Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.Clin Ther. 2012 Apr;34(4):838-48.
Mennella JA, Liem DG, Bobowski N. Taste and Smell. In : Swaiman’s Pediatric Neurology. Kenneth F. Swaiman, Stephen Ashwal, Donna M. Ferriero, Nina F. Schor, Richard S. Finkel, Andrea L. Gropman, et al. 6th ed. Philadelphia: Elsevier;2017, pp. 58-64 Available from : https://www.researchgate.net/publication/317123203
Shigemura N, Takai S, Hirose F, Yoshida R, Sanematsu K, Ninomiya Y. Expression of Renin-Angiotensin System Components in the Taste Organ of Mice. Nutrients. 2019; 11, 2251:1-18
Giani JF, Veiras LC, Shen JZY, Bernstein EA, Cao D, Okwan-Duodu D, Khan Z, Gonzalez-Villalobos RA, Bernstein KE. Novel roles of the renal angiotensin-converting enzyme. Mol Cell Endocrinol. 2021 Jun 1;529:111257.
Tikellis C, Thomas MC. Angiotensin-Converting Enzyme2(ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. International Journal of Peptides. 2012:1-8
Shigemura N, Iwata S, Yasumatsu K, Ohkuri T, Horio N, Sanematsu K, et al. Angiotensin II Modulates Salty and Sweet Taste Sensitivities. The Journal of Neuroscience. April 10,2013; 33(15):6267–77
Barrett KE, Barman SM, Boitano S, Brooks HL. Ganong’s Review of Medical Physiology Smell & Taste. In: eds., 25e. McGraw Hill; 2018. Accessed March 31, 2022. https://accessmedicine.mhmedical.com/content.aspx?bookid=1587§ionid=97163266
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host−Virus Interaction, and Proposed Neurotropic Mechanisms. [cited April 10, 2020]. Available from : https://dx.doi.org/10.1021/acschemneuro.0c00122
Huibin Lv, Wu NC, Tsang OTY, Yuan M, Perera RAPM, Leung WS, et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. BioRxiv [cited April 15, 2020]. Available from : https://www.biorxiv.org/content/10.1101/2020.03.15.993097v1
Xu H, Zhong L, Den J, Peng J, Dan H, Zeng X et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science (2020)12:8. Available from: https://doi.org/10.1038/s41368-020-0074-x
Tsuruoka S, Wakaumi, Nishiki K, Araki N, Harada K, Sugimoto K, et al. Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects. Br J Clin Pharmacol. 2004;57 :6 807–812
Clerkin KJ; Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation. 2020;141:1648–1655
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med 2020; 382:1653-1659.
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 M-Dental Education and Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.